Inventor · disambiguated record
Jerry Lanchbury
Also filed as: LANCHBURY JERRY
11 granted patents·23 pending applications·36 citations·filing 2006–2025
87Inventor score
Files withMYRIAD GENETICS INC26LABORATORY CORP AMERICA HOLDINGS3ABKEVICH VICTOR1GUTIN ALEXANDER1SKOLNICK MARK1
Top patents by PatentIndex Score
34 records- 0193US9574229B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2016·Granted Feb 21, 2017·11 cites·41 claims
- 0293US9279156B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2013·Granted Mar 8, 2016·16 cites·18 claims
- 0387US10626449B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·13 claims
- 0486US10612098B2Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2016·Granted Apr 7, 2020·2 cites·15 claims
- 0583US11225685B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2020·Granted Jan 18, 2022·1 cites·20 claims
- 0681US2023111438A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 0780US9388472B2Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2014·Granted Jul 12, 2016·3 cites·36 claims
- 0880US2025250643A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 0978US11174519B2Method of treating cancerMYRIAD GENETICS INC·Filed 2019·Granted Nov 16, 2021·0 cites·11 claims
- 1078US2022205046A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 1177US2025215509A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 1276US10851425B2Method for treating cancerMYRIAD GENETICS INC·Filed 2019·Granted Dec 1, 2020·0 cites·13 claims
- 1376US2022205022A1Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 1475US2020399713A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2020·Application pending·0 cites
- 1571US7662566B2Gene copy number profilingMYRIAD GENETICS INC·Filed 2007·Granted Feb 16, 2010·1 cites·7 claims
- 1665US2015080260A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2014·Application pending·0 cites
- 1764US2025347703A1Adjusted multi-biomarker disease activity score for inflammatory disease assessmentLABORATORY CORP AMERICA HOLDINGS·Filed 2025·Application pending·0 cites
- 1863US2023212653A1Methods and materials for assessing homologous recombination deficiency in breast cancer subtypesMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 1960US2022243276A1Methods of detecting cancerMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 2056US2012015050A1Methods and materials for assessing loss of heterozygosityABKEVICH VICTOR·Filed 2011·Application pending·0 cites
- 2156US2013143747A1Methods of detecting cancerGUTIN ALEXANDER·Filed 2011·Application pending·0 cites
- 2256US2017314081A1Methods of detecting cancerMYRIAD GENETICS INC·Filed 2017·Application pending·0 cites
- 2355US2024301500A1Global polygenic risk assessment for breast cancerMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 2454US7794933B1Depression-related geneMYRIAD GENETICS INC·Filed 2006·Granted Sep 14, 2010·0 cites·1 claims
- 2552US2024077499A1Methods for cardiovascular disease in rheumatoid arthritisLABORATORY CORP AMERICA HOLDINGS·Filed 2021·Application pending·0 cites
- 2651US2023260658A1Polygenic trait prediction using local ancestryMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 2748US2007082347A1Gene variants and use thereofMYRIAD GENETICS INC·Filed 2006·Application pending·0 cites
- 2847US2023170045A1Comprehensive polygenic risk prediction for breast cancerMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 2947US2014024028A1Brca deficiency and methods of useTIMMS KIRSTEN·Filed 2013·Application pending·0 cites
- 3044US12392785B2Adjusted multi-biomarker disease activity score for inflammatory disease assessmentLABORATORY CORP AMERICA HOLDINGS·Filed 2018·Granted Aug 19, 2025·0 cites·4 claims
- 3143US2013029926A1Compositions and methods for determing cancer susceptibilityMYRIAD GENETICS INC·Filed 2010·Application pending·0 cites
- 3242US2017137890A1Cancer prognosis signaturesMYRIAD GENETICS INC·Filed 2016·Application pending·0 cites
- 3340US2016160294A1Methods and materials for predicting response to niraparibTesaro·Filed 2015·Application pending·0 cites
- 3439US2014113310A9Cancer detection markersSKOLNICK MARK·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerry Lanchbury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →